UBM Medica US announces that Endocrinology Network, a leading online community for endocrinologists and other clinicians who treat patients with T2DM offers comprehensive and up-to-date coverage of the sodium glucose cotransporter 2 (SGLT2) inhibitors.
from The Medical News http://ift.tt/1G1QpA7
from The Medical News http://ift.tt/1G1QpA7
No comments:
Post a Comment